Clearbridge Investments, LLC Ironwood Pharmaceuticals Inc Transaction History

Clearbridge Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$11.83 - $16.2 $970 - $1,328	-82 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$12.16 - $14.58 $24,502 - $29,378	-2,015 Reduced 96.09%	82 $1,000
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $3,162 - $3,895	262 Added 14.28%	2,097 $33,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,835	1,835 $35,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.